Department of Culture and Tourism - Abu Dhabi Announces 11 December 2026 Opening of Guggenheim Abu Dhabi

Department of Culture and Tourism - Abu Dhabi Announces 11 December 2026 Opening of Guggenheim Abu Dhabi

A Landmark Museum Rooted in the United Arab Emirates and Shaping Global Artistic Dialogue Guggenheim Abu Dhabi will connect cultures, inspire people, and celebrate art from the 1960s to the present The museum brings new perspectives to modern and...

Fortune Announces 2026 Fortune Global 500 List

Fortune Announces 2026 Fortune Global 500 List

Amazon tops the list, ending Walmart's 12-year reign at No. 1 U.S. companies hit 18-year high, leading the world with 141 firms Women CEOs reach record 34 on Fortune Global 500, rising to 6.8% representation The "Magnificent Seven" generate $2.3...

Autohome Inc. Announces US$400 Million New Share Repurchase Program

Autohome Inc. Announces US$400 Million New Share Repurchase Program

BEIJING, July 28, 2026 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced that its board of directors (the "Board") has approved a...

TOMY Announces Launch of tomica's Ultimate Multi-story Parking Garage across 10 Asian Markets from September 2026; First Official Fan Community Set for October Launch

TOMY Announces Launch of tomica's Ultimate Multi-story Parking Garage across 10 Asian Markets from September 2026; First Official Fan Community Set for October Launch

TOKYO, July 28, 2026 /PRNewswire/ -- TOMY Company, Ltd., based in Katsushika-ku, Tokyo, has announced that it will release the "Automated tomica PARKING with showroom" (Suggested retail price: 41,800 yen including tax) in late September 2026. This...

Everest Medicines Announces Participation in Upcoming Investor Conferences

Everest Medicines Announces Participation in Upcoming Investor Conferences

SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...

Ohmyhome Ltd Announces Pricing of $4 Million Registered Direct Offering

Ohmyhome Ltd Announces Pricing of $4 Million Registered Direct Offering

SINGAPORE, July 27, 2026 /PRNewswire/ -- Ohmyhome Ltd (NASDAQ: OMH) (the "Company"), a data- and technology-driven digital marketing company delivering multi-channel marketing and content solutions for advertisers, today announced that it has...

HTCO Announces Ten-Year Extension of Singapore MSI-AIS Maritime Tax Exemption Through 2035

HTCO Announces Ten-Year Extension of Singapore MSI-AIS Maritime Tax Exemption Through 2035

MSI-AIS Award Extended Through 2035, Providing Long-Term Tax Certainty and Enhancing Competitive Position in Global Shipping NEW YORK, July 27, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global...

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway Global Phase 1 multicenter study evaluates safety, tolerability, and preliminary efficacy in patients with mesothelioma...

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) formulation and oral formulation will be...

Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader

Russell Reynolds Associates Announces Nick Fletcher as Australia Country Leader

SYDNEY, July 27, 2026 /PRNewswire/ --Russell Reynolds Associates today announced that Nick Fletcher, based in Melbourne and Sydney, has been appointed Australia Country Leader, succeeding Alistair Macrae, who moves into the role of Head of Asia...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 88
  • menu
    menu